BioSpace News Archive

Drug Development

GeoVax’s Novel Vaccine Platform Induces Both Antibody and T Cell Responses

GeoVax is conducting two Phase II COVID-19 vaccine clinical trials with its GEO-CMO4S1 vaccine. One of the trials is among immunocompromised patients.

April 8, 2022
·
5 min read
·
Gail Dutton
Policy

US Congress Introduces Bills to Strengthen Pharma Competition, Promote Innovation

The new bills result from a three-year investigation that honed in on anti-competitive efforts that have prevented generic drugs and biosimilars from entering the market.

April 8, 2022
·
3 min read
·
Alex Keown
Business

Everybody Wants a Piece of Moderna. Next Up: University of Toronto

The partnership framework agreement allows Moderna and U of T to collaborate across a broad variety of areas, ranging from molecular genetics to biomedical engineering, biochemistry and more.

April 8, 2022
·
3 min read
·
Mark Terry
FDA

Alnylam’s Greenstreet Takes Home $8.5M, Ex-CEO Maraganore Nets $10M

Alnylam Pharmaceuticals issued a proxy filing ahead of its May 18, 2022, Annual Meeting of Stockholders to inform stockholders of several items they can vote on at the end of the meeting.

April 8, 2022
·
3 min read
·
Mark Terry
Deals

Kaleido Biosciences Culls Staff, Prepares to Cease Operations

Shares of Kaleido Biosciences are plunging after the company announced its intentions to cease all company operations, lay off its remaining staff and delist from the Nasdaq Exchange.

April 8, 2022
·
2 min read
·
Alex Keown
Policy

COVID-19 By the Numbers: Nearly a Half Billion Global Cases and Counting

COVID-19 has killed more than six million people worldwide and almost one million in the U.S. And the pandemic isn’t over yet. Read on for that and more updates about COVID-19.

April 8, 2022
·
4 min read
·
Mark Terry
Scientists Turn Back the Clock, Make Skin Cells 30 Years Younger

Researchers at the Babraham Research Institute have developed a new technique for rejuvenating skin cells, which can rewind the biological clock of patients by about 30 years.

April 8, 2022
·
3 min read
·
Hannah Chudleigh
FDA

In Leap Forward, Triastek Takes 3D-Printed Cardiovascular Drug into the Clinic

The U.S. FDA greenlit China-based Triastek’s IND Application for its 3D printed drug product, T20, for cardiovascular and clotting disorders.

April 8, 2022
·
2 min read
·
Alex Keown
In Pew Survey, Black Americans Express Concern About Potential for Research Misconduct

55% of respondents describe misconduct by medical research scientists as being a moderate or a very big problem.

April 8, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

Clinical Catch-Up: COVID-19, AAN, ACC

It was a very busy week for clinical trial news, in part because of presentations coming out of the American Academy of Neurology (AAN) meeting. Here’s a look.

April 8, 2022
·
12 min read
·
Mark Terry